1. Home
  2. POWW vs EDIT Comparison

POWW vs EDIT Comparison

Compare POWW & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$1.73

Market Cap

210.8M

Sector

Industrials

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.02

Market Cap

202.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWW
EDIT
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.8M
202.1M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
POWW
EDIT
Price
$1.73
$2.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.38
$4.50
AVG Volume (30 Days)
364.4K
1.9M
Earning Date
02-09-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,632,638.00
$46,383,000.00
Revenue This Year
$9.85
N/A
Revenue Next Year
$1.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1343.57
N/A
52 Week Low
$1.08
$0.91
52 Week High
$2.14
$4.54

Technical Indicators

Market Signals
Indicator
POWW
EDIT
Relative Strength Index (RSI) 42.09 38.96
Support Level $1.78 $1.99
Resistance Level $1.97 $2.28
Average True Range (ATR) 0.08 0.13
MACD -0.01 0.01
Stochastic Oscillator 22.22 27.90

Price Performance

Historical Comparison
POWW
EDIT

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: